These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29769469)

  • 1. [ACTIVATION MECHANISMS OF MAST CELLS IN CHRONIC SPONTANEOUS URTICARIA].
    Okayama Y
    Arerugi; 2018; 67(3):192-196. PubMed ID: 29769469
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenesis of chronic urticaria.
    Kaplan AP; Greaves M
    Clin Exp Allergy; 2009 Jun; 39(6):777-87. PubMed ID: 19400905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omalizumab may not inhibit mast cell and basophil activation in vitro.
    Gericke J; Ohanyan T; Church MK; Maurer M; Metz M
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1832-6. PubMed ID: 25257818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion of cytokines, histamine and leukotrienes in chronic urticaria.
    Ferrer M; Luquin E; Sanchez-Ibarrola A; Moreno C; Sanz ML; Kaplan AP
    Int Arch Allergy Immunol; 2002 Nov; 129(3):254-60. PubMed ID: 12444324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation in chronic urticaria is not limited to the consequences of mast cell (or basophil) degranulation.
    Kaplan A
    Clin Exp Allergy; 2010 Jun; 40(6):834-5. PubMed ID: 20214660
    [No Abstract]   [Full Text] [Related]  

  • 6. Basophil CD63 expression in chronic spontaneous urticaria: correlation with allergic sensitization, serum autoreactivity and basophil reactivity.
    Chen Q; Zhai Z; Xu J; Chen W; Chen S; Zhong H; Huang X; Hao F; Song Z
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):463-468. PubMed ID: 27518369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for evaluation of mast cell and basophil activation.
    Kabashima K; Nakashima C; Nonomura Y; Otsuka A; Cardamone C; Parente R; De Feo G; Triggiani M
    Immunol Rev; 2018 Mar; 282(1):114-120. PubMed ID: 29431209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pathogenesis of Chronic Spontaneous Urticaria: The Role of Infiltrating Cells.
    Giménez-Arnau AM; DeMontojoye L; Asero R; Cugno M; Kulthanan K; Yanase Y; Hide M; Kaplan AP
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2195-2208. PubMed ID: 33823316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of mast cell and basophil in cold urticaria with associated systemic reactions.
    JUHLIN L; SHELLEY WB
    JAMA; 1961 Aug; 177():371-7. PubMed ID: 13790975
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to: Bias in the use of a SSClow/CCR3pos gate to capture basophils in chronic urticaria?
    D'Auria E; De Amici M; Licari A; Caimmi S; Mantegazza C; Zuccotti GV; Marseglia GL
    Immunobiology; 2020 Jan; 225(1):151852. PubMed ID: 31630898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: Novel insights into inflammatory roles of mast cells and basophils.
    Tanaka S; Van Overveld FJ
    Front Immunol; 2023; 14():1186264. PubMed ID: 37033998
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoreactive IgE in Chronic Spontaneous/Idiopathic Urticaria and Basophil/Mastocyte Priming Phenomenon, as a Feature of Autoimmune Nature of the Syndrome.
    Panaszek B; Pawłowicz R; Grzegrzółka J; Obojski A
    Arch Immunol Ther Exp (Warsz); 2017 Apr; 65(2):137-143. PubMed ID: 27582030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basophil Activation Test identifies the patients with Chronic Spontaneous Urticaria suffering the most active disease.
    Curto-Barredo L; Yelamos J; Gimeno R; Mojal S; Pujol RM; Giménez-Arnau A
    Immun Inflamm Dis; 2016 Dec; 4(4):441-445. PubMed ID: 27980778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basophil/mast cell precursors in mast cell proliferative disorders.
    Denburg JA; Telizyn S; Ahlstedt S; Olafsson JH; Roupe G; Bienenstock J
    Clin Invest Med; 1986; 9(1):21-5. PubMed ID: 3955917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparable actions of omalizumab on mast cells and basophils.
    Serrano-Candelas E; Martinez-Aranguren R; Valero A; Bartra J; Gastaminza G; Goikoetxea MJ; Martín M; Ferrer M
    Clin Exp Allergy; 2016 Jan; 46(1):92-102. PubMed ID: 26509363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells.
    Asero R; Lorini M; Chong SU; Zuberbier T; Tedeschi A
    Clin Exp Allergy; 2004 Jul; 34(7):1111-4. PubMed ID: 15248858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.
    Kaplan AP; Giménez-Arnau AM; Saini SS
    Allergy; 2017 Apr; 72(4):519-533. PubMed ID: 27861988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basophils in chronic urticaria.
    Grattan CE
    J Investig Dermatol Symp Proc; 2001 Nov; 6(2):139-40. PubMed ID: 11764301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of basophil-activating IgG autoantibodies in chronic idiopathic urticaria by induction of CD 63.
    De Swerdt A; Van Den Keybus C; Kasran A; Cadot P; Neyens K; Coorevits L; Kochuyt AM; Degreef H; Ceuppens JL
    J Allergy Clin Immunol; 2005 Sep; 116(3):662-7. PubMed ID: 16159640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual IL-3 priming is crucial for consistent in vitro activation of donor basophils in patients with chronic urticaria.
    Gentinetta T; Pecaric-Petkovic T; Wan D; Falcone FH; Dahinden CA; Pichler WJ; Hausmann OV
    J Allergy Clin Immunol; 2011 Dec; 128(6):1227-1234.e5. PubMed ID: 21855127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.